Calcium and magnesium levels during automated plateletpheresis in normal donors

被引:30
作者
Das, SS
Chaudhary, R
Khetan, D
Shukla, JS
Agarwal, P
Mishra, RB
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Transfus Med, Lucknow 226014, Uttar Pradesh, India
[2] Ind Toxicol Res Ctr, Photobiol Div, Lucknow 226001, Uttar Pradesh, India
关键词
blood donor; electrolytes; plateletpheresis;
D O I
10.1111/j.1365-3148.2005.00576.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is well known that citrate induces ionized hypocalcaemia by the chelating effect during plateletpheresis. However, the kinetics of serum magnesium (Mg) ions has not been well documented. We, therefore, evaluated biochemical changes in healthy donors during plateletpheresis procedure. Ten healthy donors underwent plateletpheresis on continuous cell separator (CS3000, Baxter, Round Lake, IL, USA) and 10 on intermittent flow cell separator (MCS 3p, Hemonetics, Braintree, MA, USA). Serum levels of total and ionized calcium (tCa and iCa, respectively) and Mg (tMg and iMg, respectively) were measured before, during and after the procedures. Although, the fall in tCa (from 2.62 +/- 0.12 to 2.36 +/- 0.12 mmol L-1) and modest and not significant; drop in iCa (frorn 1.33 +/- 0.1 to 0.84 +/- 0.1 mmol L-1) and iMg (from 0.53 +/- 0.01 to 0.35 +/- 0.1 mmol L-1) was statistically significant (P < 0.001). There were no significant differences observed between the CS3000 and MCS 3p cell separators regarding the fall in Ca and Mg. None of the donors experienced any adverse reactions during the procedures. In the study, an acute ionized hypocalcaemia and hypomagnesaemia have been observed after the plateletpheresis; therefore, measurement of both the ions may be monitored. However, there is no justification for prophylactic supplementation of either of these elements.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 13 条
  • [1] ALTERATIONS IN PLASMA MAGNESIUM CONCENTRATIONS DURING LIVER-TRANSPLANTATION
    BENNETT, MWR
    WEBSTER, NR
    SADEK, SA
    [J]. TRANSPLANTATION, 1993, 56 (04) : 859 - 861
  • [2] Boogaerts M A, 1987, Transfus Med Rev, V1, P186, DOI 10.1016/S0887-7963(87)70021-2
  • [3] MAGNESIUM - THE 5TH BUT FORGOTTEN ELECTROLYTE
    ELIN, RJ
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (05) : 616 - 622
  • [4] How to stabilize the level of ionized calcium and citrate during plateletpheresis
    Farrokhi, P
    Farahmand, H
    Bismuth, A
    Suarez, C
    Ducot, B
    Gillon, MC
    Debat, P
    Laskowski, P
    Pinon, F
    [J]. VOX SANGUINIS, 1998, 74 (01) : 7 - 12
  • [5] Glaser A, 1999, INFUSIONSTHERAPIE, V26, P300
  • [6] TORSADE-DE-POINTES AND LONG QT SYNDROME FOLLOWING MAJOR BLOOD-TRANSFUSION
    KULKARNI, P
    BHATTACHARYA, S
    PETROS, AJ
    [J]. ANAESTHESIA, 1992, 47 (02) : 125 - 127
  • [7] QTc prolongation in apheresis platelet donors
    Laspina, SJ
    Browne, MA
    McSweeney, EN
    Lawlor, J
    Whelan, DM
    Kinsella, AI
    Murphy, WG
    [J]. TRANSFUSION, 2002, 42 (07) : 899 - 903
  • [8] Frequency of immediate adverse effects associated with apheresis donation
    McLeod, BC
    Price, TH
    Owen, H
    Ciavarella, D
    Sniecinski, I
    Randels, MJ
    Smith, JW
    [J]. TRANSFUSION, 1998, 38 (10) : 938 - 943
  • [9] Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis
    Mercan, D
    Bastin, G
    Lambermont, M
    Dupont, E
    [J]. TRANSFUSION, 1997, 37 (04) : 418 - 422
  • [10] REBEYKA IM, 1990, CIRCULATION, V82, P367